Search

The primary objective of this investigation was to explore the beneficial impacts of Enteromorpha prolifera polysaccharide (EP) on dysglycemia in Zucker diabetic fatty (ZDF) rats, while also shedding light on its potential mechanism using 1H‐NMR‐based metabolomics. The results demonstrated a noteworthy reduction in fasting blood glucose (FBG, 46.3%), fasting insulin (50.17%), glycosylated hemoglobin A1c (HbA1c, 44.1%), and homeostatic model assessment of insulin resistance (HOMA‐IR, 59.75%) following EP administration, while the insulin sensitivity index (ISI, 19.6%) and homeostatic model assessment of β‐cell function (HOMA‐β, 2.5‐fold) were significantly increased. These findings indicate that EP enhances β‐cell function, increases insulin sensitivity, and improves insulin resistance caused by diabetes. Moreover, EP significantly reduced serum lipid levels, suggesting improvement of dyslipidemia. Through the analysis of serum metabolomics, 17 metabolites were found to be altered in diabetic rats, 14 of which were upregulated and 3 of which were downregulated. Notably, the administration of EP successfully reversed the abnormal levels of 9 out of the 17 metabolites. Pathway analysis further revealed that EP treatment partially restored metabolic dysfunction, with notable effects observed in valine, leucine, and isoleucine metabolism; aminoacyl‐transfer RNA (tRNA) biosynthesis; and ketone body metabolism. These findings collectively indicate the potential therapeutic efficacy of EP in preventing glycemic abnormalities and improving insulin resistance. Thus, EP holds promise as a valuable treatment option for individuals with diabetes. [ABSTRACT FROM AUTHOR]

A procedure was evaluated for the extraction of 16 free fatty acids (FFAs) from liver. Ultrasonic energy was used for the extraction and the variables affecting the extraction efficiency were investigated. The best conditions for extraction were: 2 mL isopropanol–n-hexane (3:2, v/v), 20 min and 80 w. Recoveries ranging from 87.00 to 120.00% were obtained under the optimum conditions, and the linearity as correlation coefficient was higher than 0.9914. Analytical results for the 16 FFAs in the same liver sample, analyzed by ultrasound-assisted and conventional extraction, showed acceptable agreement, thus suggesting the possibility of using ultrasound-assisted extraction instead of the conventional procedure. Moreover, the ultrasound-assisted extraction was successfully applied to the determination of FFAs in the liver of mice with hyperlipidemia and normal mice. [ABSTRACT FROM PUBLISHER]

The primary objective of this investigation was to explore the beneficial impacts of Enteromorpha prolifera polysaccharide (EP) on dysglycemia in Zucker diabetic fatty (ZDF) rats, while also shedding light on its potential mechanism using 1 H-NMR-based metabolomics. The results demonstrated a noteworthy reduction in fasting blood glucose (FBG, 46.3%), fasting insulin (50.17%), glycosylated hemoglobin A1c (HbA1c, 44.1%), and homeostatic model assessment of insulin resistance (HOMA-IR, 59.75%) following EP administration, while the insulin sensitivity index (ISI, 19.6%) and homeostatic model assessment of β-cell function (HOMA-β, 2.5-fold) were significantly increased. These findings indicate that EP enhances β-cell function, increases insulin sensitivity, and improves insulin resistance caused by diabetes. Moreover, EP significantly reduced serum lipid levels, suggesting improvement of dyslipidemia. Through the analysis of serum metabolomics, 17 metabolites were found to be altered in diabetic rats, 14 of which were upregulated and 3 of which were downregulated. Notably, the administration of EP successfully reversed the abnormal levels of 9 out of the 17 metabolites. Pathway analysis further revealed that EP treatment partially restored metabolic dysfunction, with notable effects observed in valine, leucine, and isoleucine metabolism; aminoacyl-transfer RNA (tRNA) biosynthesis; and ketone body metabolism. These findings collectively indicate the potential therapeutic efficacy of EP in preventing glycemic abnormalities and improving insulin resistance. Thus, EP holds promise as a valuable treatment option for individuals with diabetes., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to exert influence on the research presented in this manuscript., (© 2024 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.)

Objective: To compare the differences in microbial community between lactating mothers with gestational diabetes mellitus(GDM) and normal glucose tolerance lactating mothers(control) at 42 days postpartum, and to explore the effect of GDM on the microbial composition and structure of breast milk., Methods: A total of 21 mothers with GDM and 25 healthy mothers in Fuqing Maternity and Child Health Care Hospital at 42 days postpartum from May 2019 to September 2020 were enrolled. A questionnaire was used to collect the basic information and dietary intakes of mothers. The mother's milk was collected by using a sterile electric breast pump. Breast milk microbiota profiles were assessed by 16 S rDNA gene amplicon based sequencing of the V3-V4 region and the sequencing platform was Illumina Miseq PE3000, bioinformatics analysis was performed on the sequencing result., Results: Compared with the control group, the mothers in the GDM group consumed more vegetables(222.7(190.6, 333.1)g/d vs.176.4(49.5, 247.0)g/d, P=0.042). There was no significant difference in Alpha diversity between the two groups(P>0.05). Beta diversity analysis showed that there were significant differences in the microbial composition between the two groups(P<0.01). Breast milk microbiota species difference analysis showed that there were differences in several species between GDM group and NGT group at the levels from phylum to genus. Compared with control group, the relative abundance of Bacteroidota and Cyanobacteria in GDM group decreased significantly [(3.41±2.59)% vs. (1.23±0.82)%, (1.08±3.02)% vs. (0.10±0.11)%, P<0.05]. In the GDM group, Ralstonia, Rhodococcus, Burkholderia-Caballeronia-Paraburkholderia, Acinetobacter and Fluviicola were decreased((38.93±28.85)% vs. (26.70±28.37)%, (9.23±6.87)% vs. (4.88±6.03)%, (7.66±4.80)% vs. (2.77±1.33)%, (6.18±11.90)% vs. (2.76±6.10)%, (1.21±1.31)% vs. (0.33±0.62)%, P<0.05). The unclassified＿f＿＿xanthobacteraceae was increased, and the difference was statistically significant((0.85±3.15)% vs. (23.64±23.63)%, P<0.05)., Conclusion: There are differences in breast milk microbial community structure in women with different glucose tolerance at 42 days postpartum, Ralstonia, Rhodococcus, Burkholderia-Caballeronia-Paraburkholderia, Acinetobacter and Fluviicola were significantly lower comparing to the normal glucose tolerance mothers.

It has been demonstrated that mangiferin can ameliorate hypertriglyceridemia by modulating the expression levels of genes involved in lipid metabolism in animal experiments, but its effects on the serum metabolic fingerprinting of hyperlipidemia animal models have not been reported. Thus, a NMR-based metabolomics approach was conducted to explore the effects of mangiferin on hyperlipidemia hamsters and to gain a better understanding of the involved metabolic pathways. Hamsters fed with a high-fat diet were orally administered with mangiferin 150 mg per kg BW once a day for 8 weeks. Serum samples were analysed by 1 H NMR, and multivariate statistical analysis was applied to the data to identify potential biomarkers. In total, 20 discriminating metabolites were identified. It turned out that mangiferin administration can partly reverse the metabolism disorders induced by a high-fat diet and exerted a good anti-hypertriglyceridemia effect. Mangiferin ameliorated hyperlipidemia by intervening in some major metabolic pathways, involving glycolysis, the TCA cycle, synthesis of ketone bodies, and BCAAs as well as choline and lipid metabolism. These findings provided new essential information on the effects of mangiferin and demonstrated the great potential of this nutrimetabolomics approach.

The aim of current study was to investigate the metabolic changes associated with histidine supplementation in serum and urine metabolic signatures and serum amino acid (AA) profiles. Serum and urine 1 H NMR-based metabolomics and serum AA profiles were employed in 32 and 37 obese women with metabolic syndrome (MetS) intervened with placebo or histidine for 12 weeks. Multivariable statistical analysis were conducted to define characteristic metabolites. In serum 1 H NMR metabolic profiles, increases in histidine, glutamine, aspartate, glycine, choline, and trimethylamine-N-oxide (TMAO) were observed; meanwhile, decreases in cholesterol, triglycerides, fatty acids and unsaturated lipids, acetone, and α/β-glucose were exhibited after histidine supplement. In urine 1 H NMR metabolic profiles, citrate, creatinine/creatine, methylguanidine, and betaine + TMAO were higher, while hippurate was lower in histidine supplement group. In serum AA profiles, 10 AAs changed after histidine supplementation, including increased histidine, glycine, alanine, lysine, asparagine, and tyrosine and decreased leucine, isoleucine, ornithine, and citrulline. The study showed a systemic metabolic response in serum and urine metabolomics and AA profiles to histidine supplementation, showing significantly changed metabolism in AAs, lipid, and glucose in obese women with MetS.

Objective: To provide a basis for establishing better animal models with hyperlipidemia by comparing the effects of two different high-fat diets on blood lipids of rats., Methods: 30 male Wistar rats were randomly divided into 3 groups (10 rats in each group) , including normal control group (NC), high fat formula diet group I (HFFD I) and high fat formula diet group II (HFFD II). NC group was fed a stock rodent diet, the HFFD I and HFFD II were fed with different high-fat formulae diets. Animals were weighted weekly and blood lipids were determined every two weeks. The experiment lasted for 6 weeks., Results: By the end of the experiment, serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in HFFD I group were 1.4 and 2.2 times higher than those of the NC group (P < 0.01). Serum high-density lipoprotein cholesterol (HDL-C) was 22.2% lower than that of NC group. Serum triglyceride (TG) was not significantly different between HFFD I and NC group (P > 0.05). Serum TC and LDL-C of HFFD II group were 11.5 and 5.7 times respectively higher than those of the NC group (P < 0.01). Serum TG and HDL-C were 39.7% and 34.6% respectively lower than those of the NC group., Conclusion: Animal models with hypercholesteremia can be successfully established by the two methods, but the serum TG level of the rats can not be significantly elevated.